

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 8.70437879 |
| 2 | synaptic vesicle maturation (GO:0016188) | 7.30986363 |
| 3 | ensheathment of neurons (GO:0007272) | 7.19599339 |
| 4 | axon ensheathment (GO:0008366) | 7.19599339 |
| 5 | myelination (GO:0042552) | 7.16314829 |
| 6 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 7.02185772 |
| 7 | glutamate secretion (GO:0014047) | 6.63321762 |
| 8 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.52505867 |
| 9 | synaptic vesicle exocytosis (GO:0016079) | 6.10355778 |
| 10 | cellular potassium ion homeostasis (GO:0030007) | 5.80186022 |
| 11 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.68333096 |
| 12 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.64644972 |
| 13 | cholesterol biosynthetic process (GO:0006695) | 5.63358687 |
| 14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.61076989 |
| 15 | myelin maintenance (GO:0043217) | 5.47937354 |
| 16 | sodium ion export (GO:0071436) | 5.24615345 |
| 17 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.20022001 |
| 18 | sterol biosynthetic process (GO:0016126) | 4.98565165 |
| 19 | neurotransmitter secretion (GO:0007269) | 4.95781496 |
| 20 | establishment of mitochondrion localization (GO:0051654) | 4.92521498 |
| 21 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.89219181 |
| 22 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.87089396 |
| 23 | regulation of synaptic vesicle transport (GO:1902803) | 4.86050456 |
| 24 | neuronal ion channel clustering (GO:0045161) | 4.85780090 |
| 25 | negative regulation of protein localization to cell surface (GO:2000009) | 4.77219229 |
| 26 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.76547618 |
| 27 | locomotory exploration behavior (GO:0035641) | 4.71718911 |
| 28 | negative regulation of neurotransmitter transport (GO:0051589) | 4.71108670 |
| 29 | neuronal action potential propagation (GO:0019227) | 4.67576454 |
| 30 | oligodendrocyte differentiation (GO:0048709) | 4.63112483 |
| 31 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.57297773 |
| 32 | glycerophospholipid catabolic process (GO:0046475) | 4.57177754 |
| 33 | potassium ion import (GO:0010107) | 4.57153077 |
| 34 | regulation of collateral sprouting (GO:0048670) | 4.54306714 |
| 35 | potassium ion homeostasis (GO:0055075) | 4.53742368 |
| 36 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.52133367 |
| 37 | postsynaptic membrane organization (GO:0001941) | 4.50152062 |
| 38 | creatine metabolic process (GO:0006600) | 4.50066842 |
| 39 | isoprenoid biosynthetic process (GO:0008299) | 4.48432872 |
| 40 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 4.37790685 |
| 41 | response to methylmercury (GO:0051597) | 4.29890999 |
| 42 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.27471185 |
| 43 | amyloid precursor protein metabolic process (GO:0042982) | 4.25606352 |
| 44 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.21788597 |
| 45 | vocalization behavior (GO:0071625) | 4.21129768 |
| 46 | cerebellar granule cell differentiation (GO:0021707) | 4.19107977 |
| 47 | neurotransmitter transport (GO:0006836) | 4.15730631 |
| 48 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.12605454 |
| 49 | apical protein localization (GO:0045176) | 4.09718554 |
| 50 | L-amino acid import (GO:0043092) | 4.07663398 |
| 51 | astrocyte development (GO:0014002) | 4.07601916 |
| 52 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.04678393 |
| 53 | response to redox state (GO:0051775) | 4.03581841 |
| 54 | presynaptic membrane organization (GO:0097090) | 4.02401340 |
| 55 | photoreceptor cell differentiation (GO:0046530) | 4.01583983 |
| 56 | eye photoreceptor cell differentiation (GO:0001754) | 4.01583983 |
| 57 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.95424552 |
| 58 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.95340901 |
| 59 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.95320499 |
| 60 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.94411267 |
| 61 | positive regulation of synapse maturation (GO:0090129) | 3.93926626 |
| 62 | substantia nigra development (GO:0021762) | 3.91752979 |
| 63 | gamma-aminobutyric acid transport (GO:0015812) | 3.90887900 |
| 64 | asymmetric protein localization (GO:0008105) | 3.86837975 |
| 65 | response to lipoprotein particle (GO:0055094) | 3.85532766 |
| 66 | exploration behavior (GO:0035640) | 3.84657601 |
| 67 | synaptic transmission, glutamatergic (GO:0035249) | 3.82886132 |
| 68 | regulation of neurotransmitter levels (GO:0001505) | 3.80689481 |
| 69 | acidic amino acid transport (GO:0015800) | 3.80383318 |
| 70 | import into cell (GO:0098657) | 3.79735080 |
| 71 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.77908195 |
| 72 | membrane tubulation (GO:0097320) | 3.77042834 |
| 73 | regulation of lipoprotein metabolic process (GO:0050746) | 3.74027803 |
| 74 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.70216433 |
| 75 | regulation of synaptic plasticity (GO:0048167) | 3.64794178 |
| 76 | regulation of neurotransmitter secretion (GO:0046928) | 3.64253040 |
| 77 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.63321999 |
| 78 | GPI anchor biosynthetic process (GO:0006506) | 3.61991666 |
| 79 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.61584958 |
| 80 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.56613432 |
| 81 | positive regulation of membrane potential (GO:0045838) | 3.55791910 |
| 82 | regulation of neurotransmitter transport (GO:0051588) | 3.51364235 |
| 83 | GPI anchor metabolic process (GO:0006505) | 3.50515617 |
| 84 | long-term synaptic potentiation (GO:0060291) | 3.50377264 |
| 85 | protein palmitoylation (GO:0018345) | 3.50265682 |
| 86 | glutamate receptor signaling pathway (GO:0007215) | 3.49850990 |
| 87 | neuromuscular process controlling balance (GO:0050885) | 3.49739682 |
| 88 | cellular sodium ion homeostasis (GO:0006883) | 3.49202061 |
| 89 | presynaptic membrane assembly (GO:0097105) | 3.49080815 |
| 90 | neuron-neuron synaptic transmission (GO:0007270) | 3.48764853 |
| 91 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.47674735 |
| 92 | positive regulation of dendritic spine development (GO:0060999) | 3.47073164 |
| 93 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.45841553 |
| 94 | adhesion of symbiont to host cell (GO:0044650) | 3.44435482 |
| 95 | virion attachment to host cell (GO:0019062) | 3.44435482 |
| 96 | regulation of synapse structural plasticity (GO:0051823) | 3.42300931 |
| 97 | magnesium ion transport (GO:0015693) | 3.41685121 |
| 98 | protein localization to synapse (GO:0035418) | 3.40707165 |
| 99 | L-glutamate transport (GO:0015813) | 3.38887694 |
| 100 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.37753781 |
| 101 | very long-chain fatty acid metabolic process (GO:0000038) | 3.37404677 |
| 102 | cell communication by electrical coupling (GO:0010644) | 3.33067774 |
| 103 | proline transport (GO:0015824) | 3.29856786 |
| 104 | regulation of postsynaptic membrane potential (GO:0060078) | 3.28088752 |
| 105 | axon development (GO:0061564) | 3.26794523 |
| 106 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.23316739 |
| 107 | myelination in peripheral nervous system (GO:0022011) | 3.22945878 |
| 108 | peripheral nervous system axon ensheathment (GO:0032292) | 3.22945878 |
| 109 | glycosylceramide metabolic process (GO:0006677) | 3.22853410 |
| 110 | regulation of dendritic spine development (GO:0060998) | 3.22228397 |
| 111 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.21686818 |
| 112 | neuron remodeling (GO:0016322) | 3.21278493 |
| 113 | synaptic vesicle endocytosis (GO:0048488) | 3.21244539 |
| 114 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.20059486 |
| 115 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.19019530 |
| 116 | thioester biosynthetic process (GO:0035384) | 3.17534569 |
| 117 | acyl-CoA biosynthetic process (GO:0071616) | 3.17534569 |
| 118 | protein neddylation (GO:0045116) | 3.17192626 |
| 119 | regulation of synapse maturation (GO:0090128) | 3.17146520 |
| 120 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.15949627 |
| 121 | adult walking behavior (GO:0007628) | 3.15484266 |
| 122 | regulation of vesicle fusion (GO:0031338) | 3.15377655 |
| 123 | membrane depolarization during action potential (GO:0086010) | 3.15020189 |
| 124 | amyloid precursor protein catabolic process (GO:0042987) | 3.12726043 |
| 125 | long-term memory (GO:0007616) | 3.12633294 |
| 126 | dendritic spine morphogenesis (GO:0060997) | 3.12570223 |
| 127 | astrocyte differentiation (GO:0048708) | 3.11281757 |
| 128 | regulation of synaptic transmission (GO:0050804) | 3.10793530 |
| 129 | neuromuscular process controlling posture (GO:0050884) | 3.09517991 |
| 130 | auditory behavior (GO:0031223) | 3.08646244 |
| 131 | regulation of ARF protein signal transduction (GO:0032012) | 3.06558958 |
| 132 | detection of calcium ion (GO:0005513) | 3.06450708 |
| 133 | limb bud formation (GO:0060174) | 3.04979216 |
| 134 | negative regulation of JUN kinase activity (GO:0043508) | 3.04330907 |
| 135 | negative regulation of axonogenesis (GO:0050771) | 3.03323336 |
| 136 | membrane depolarization (GO:0051899) | 3.03267322 |
| 137 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.00354465 |
| 138 | synaptic transmission (GO:0007268) | 2.99609662 |
| 139 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.98070707 |
| 140 | positive regulation of neurotransmitter transport (GO:0051590) | 2.96169111 |
| 141 | heme transport (GO:0015886) | 2.94397287 |
| 142 | iron coordination entity transport (GO:1901678) | 2.90095713 |
| 143 | amino acid import (GO:0043090) | 2.89664925 |
| 144 | peptidyl-cysteine modification (GO:0018198) | 2.86323109 |
| 145 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.86165761 |
| 146 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.85353344 |
| 147 | L-phenylalanine catabolic process (GO:0006559) | 2.85353344 |
| 148 | organ growth (GO:0035265) | 2.84722298 |
| 149 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.84606139 |
| 150 | glial cell development (GO:0021782) | 2.82377742 |
| 151 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.82238050 |
| 152 | neurotransmitter uptake (GO:0001504) | 2.81644615 |
| 153 | positive regulation of glial cell differentiation (GO:0045687) | 2.79211370 |
| 154 | nucleotide transmembrane transport (GO:1901679) | 2.77743086 |
| 155 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.74252415 |
| 156 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.74252415 |
| 157 | Golgi to endosome transport (GO:0006895) | 2.72943251 |
| 158 | positive regulation of pseudopodium assembly (GO:0031274) | 2.72043688 |
| 159 | positive regulation of action potential (GO:0045760) | 2.72012947 |
| 160 | cellular response to epinephrine stimulus (GO:0071872) | 2.68762815 |
| 161 | peripheral nervous system development (GO:0007422) | 2.68298464 |
| 162 | response to dietary excess (GO:0002021) | 2.67708029 |
| 163 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.67217425 |
| 164 | negative regulation of acute inflammatory response (GO:0002674) | 2.64946129 |
| 165 | microtubule polymerization or depolymerization (GO:0031109) | 2.62579328 |
| 166 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.61611821 |
| 167 | neural nucleus development (GO:0048857) | 2.60337232 |
| 168 | nerve growth factor signaling pathway (GO:0038180) | 2.57984504 |
| 169 | response to lead ion (GO:0010288) | 2.57976264 |
| 170 | positive regulation of gliogenesis (GO:0014015) | 2.57286522 |
| 171 | transmission of nerve impulse (GO:0019226) | 2.55647961 |
| 172 | neuron cell-cell adhesion (GO:0007158) | 2.55579389 |
| 173 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.54613091 |
| 174 | mannosylation (GO:0097502) | 2.52872041 |
| 175 | glial cell differentiation (GO:0010001) | 2.51313791 |
| 176 | adhesion of symbiont to host (GO:0044406) | 2.49505232 |
| 177 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.48754033 |
| 178 | central nervous system myelination (GO:0022010) | 12.6981115 |
| 179 | axon ensheathment in central nervous system (GO:0032291) | 12.6981115 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.53683604 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.31937742 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.27827934 |
| 4 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.95610942 |
| 5 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.82216983 |
| 6 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.51538000 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.50791164 |
| 8 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.46249161 |
| 9 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.28046186 |
| 10 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.20719897 |
| 11 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.18395491 |
| 12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.15818499 |
| 13 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.11864559 |
| 14 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.07939091 |
| 15 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.05816024 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.03328257 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.95720210 |
| 18 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.94262712 |
| 19 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.91894261 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.89487707 |
| 21 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.86599973 |
| 22 | VDR_22108803_ChIP-Seq_LS180_Human | 1.85087113 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.82571139 |
| 24 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.82179198 |
| 25 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.82179198 |
| 26 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.81628658 |
| 27 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.81491249 |
| 28 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.80889896 |
| 29 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.76122435 |
| 30 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.74689019 |
| 31 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.73402663 |
| 32 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.71678035 |
| 33 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.71627068 |
| 34 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.69518759 |
| 35 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.64811231 |
| 36 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.64546680 |
| 37 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.55048248 |
| 38 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.54477533 |
| 39 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.54273457 |
| 40 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.50833376 |
| 41 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.50009745 |
| 42 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.49958443 |
| 43 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.49297236 |
| 44 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.48270026 |
| 45 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.47163416 |
| 46 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.45175759 |
| 47 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.44725107 |
| 48 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.42444654 |
| 49 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.41044390 |
| 50 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.39275213 |
| 51 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.37958298 |
| 52 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37462162 |
| 53 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.35541812 |
| 54 | KDM2B_26808549_Chip-Seq_K562_Human | 1.33804221 |
| 55 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.33152149 |
| 56 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.32531036 |
| 57 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.31768674 |
| 58 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30923617 |
| 59 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.29264013 |
| 60 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.29264013 |
| 61 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.29171159 |
| 62 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.28900820 |
| 63 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.26724447 |
| 64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.26693148 |
| 65 | FUS_26573619_Chip-Seq_HEK293_Human | 1.25457688 |
| 66 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.24821912 |
| 67 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22845104 |
| 68 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.20633858 |
| 69 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.20046335 |
| 70 | P300_19829295_ChIP-Seq_ESCs_Human | 1.18980458 |
| 71 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.18906905 |
| 72 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.18721102 |
| 73 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.18466738 |
| 74 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.17766420 |
| 75 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.17474447 |
| 76 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.14599469 |
| 77 | AR_19668381_ChIP-Seq_PC3_Human | 1.14017783 |
| 78 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.13926117 |
| 79 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.12845797 |
| 80 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.12065148 |
| 81 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.11988144 |
| 82 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.10738739 |
| 83 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.08922236 |
| 84 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.08072574 |
| 85 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07525862 |
| 86 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.07368688 |
| 87 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.07146479 |
| 88 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.06077136 |
| 89 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.05945697 |
| 90 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.05318475 |
| 91 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.05018604 |
| 92 | STAT3_23295773_ChIP-Seq_U87_Human | 1.04214420 |
| 93 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.03635163 |
| 94 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03034939 |
| 95 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.03026875 |
| 96 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.02753484 |
| 97 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.02591821 |
| 98 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01927729 |
| 99 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01253953 |
| 100 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.00915060 |
| 101 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.00690425 |
| 102 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.00447010 |
| 103 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.98587175 |
| 104 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.98514402 |
| 105 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.98333906 |
| 106 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98186002 |
| 107 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.97716544 |
| 108 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.97336503 |
| 109 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.96455116 |
| 110 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.95108111 |
| 111 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94856339 |
| 112 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.94143940 |
| 113 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.94016647 |
| 114 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93662305 |
| 115 | TCF4_23295773_ChIP-Seq_U87_Human | 0.92557237 |
| 116 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.92379495 |
| 117 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 0.92321298 |
| 118 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.92133003 |
| 119 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91583932 |
| 120 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.91508191 |
| 121 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89860511 |
| 122 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89839395 |
| 123 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.87747984 |
| 124 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.87464829 |
| 125 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 0.87388225 |
| 126 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 0.87388225 |
| 127 | TBL1_22424771_ChIP-Seq_293T_Human | 0.87289281 |
| 128 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.85540699 |
| 129 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.85249559 |
| 130 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.85152145 |
| 131 | * DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.84734944 |
| 132 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.84248447 |
| 133 | KDM2B_26808549_Chip-Seq_REH_Human | 0.84188308 |
| 134 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.83940028 |
| 135 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.83324562 |
| 136 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.82713804 |
| 137 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.82569244 |
| 138 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.82354967 |
| 139 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.82349365 |
| 140 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.81974810 |
| 141 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.81257519 |
| 142 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81257519 |
| 143 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.80963563 |
| 144 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.80066656 |
| 145 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77779675 |
| 146 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.76993306 |
| 147 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.75634506 |
| 148 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.73021025 |
| 149 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.71383332 |
| 150 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.70693293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0000920_abnormal_myelination | 5.67615382 |
| 2 | MP0003950_abnormal_plasma_membrane | 3.91240880 |
| 3 | MP0003880_abnormal_central_pattern | 3.69640209 |
| 4 | MP0004270_analgesia | 3.33712356 |
| 5 | MP0003690_abnormal_glial_cell | 3.13805441 |
| 6 | MP0001529_abnormal_vocalization | 3.06096693 |
| 7 | MP0003329_amyloid_beta_deposits | 2.91237654 |
| 8 | MP0004885_abnormal_endolymph | 2.66265178 |
| 9 | MP0001905_abnormal_dopamine_level | 2.59491344 |
| 10 | MP0003136_yellow_coat_color | 2.56214353 |
| 11 | MP0004742_abnormal_vestibular_system | 2.54501894 |
| 12 | MP0005171_absent_coat_pigmentation | 2.51240280 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.46992937 |
| 14 | MP0002272_abnormal_nervous_system | 2.46031377 |
| 15 | MP0003634_abnormal_glial_cell | 2.45555035 |
| 16 | MP0001486_abnormal_startle_reflex | 2.40007223 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.20369033 |
| 18 | MP0001485_abnormal_pinna_reflex | 2.19488636 |
| 19 | MP0005451_abnormal_body_composition | 2.17384903 |
| 20 | MP0005409_darkened_coat_color | 2.16699909 |
| 21 | MP0002064_seizures | 2.10600983 |
| 22 | MP0005410_abnormal_fertilization | 2.08950635 |
| 23 | MP0000778_abnormal_nervous_system | 2.08616013 |
| 24 | MP0003787_abnormal_imprinting | 1.99352553 |
| 25 | MP0002229_neurodegeneration | 1.94125961 |
| 26 | MP0003879_abnormal_hair_cell | 1.92952162 |
| 27 | MP0004043_abnormal_pH_regulation | 1.91668044 |
| 28 | MP0010678_abnormal_skin_adnexa | 1.89930598 |
| 29 | MP0005423_abnormal_somatic_nervous | 1.89763520 |
| 30 | MP0004859_abnormal_synaptic_plasticity | 1.75923754 |
| 31 | MP0005646_abnormal_pituitary_gland | 1.74742545 |
| 32 | MP0000383_abnormal_hair_follicle | 1.74062831 |
| 33 | MP0009780_abnormal_chondrocyte_physiolo | 1.73213478 |
| 34 | MP0001984_abnormal_olfaction | 1.68917769 |
| 35 | MP0001502_abnormal_circadian_rhythm | 1.68360273 |
| 36 | MP0000462_abnormal_digestive_system | 1.66352338 |
| 37 | MP0009046_muscle_twitch | 1.63848810 |
| 38 | MP0004811_abnormal_neuron_physiology | 1.61776774 |
| 39 | MP0002734_abnormal_mechanical_nocicepti | 1.60915874 |
| 40 | * MP0003632_abnormal_nervous_system | 1.60020483 |
| 41 | MP0000604_amyloidosis | 1.58136066 |
| 42 | * MP0004142_abnormal_muscle_tone | 1.57878872 |
| 43 | MP0009745_abnormal_behavioral_response | 1.54787620 |
| 44 | MP0004381_abnormal_hair_follicle | 1.54368023 |
| 45 | MP0004147_increased_porphyrin_level | 1.54131540 |
| 46 | MP0002557_abnormal_social/conspecific_i | 1.53317236 |
| 47 | MP0003635_abnormal_synaptic_transmissio | 1.46801685 |
| 48 | MP0004134_abnormal_chest_morphology | 1.46108097 |
| 49 | MP0005551_abnormal_eye_electrophysiolog | 1.43829995 |
| 50 | MP0005167_abnormal_blood-brain_barrier | 1.42645165 |
| 51 | * MP0003631_nervous_system_phenotype | 1.32649541 |
| 52 | MP0008260_abnormal_autophagy | 1.32399505 |
| 53 | MP0002882_abnormal_neuron_morphology | 1.29949765 |
| 54 | MP0003195_calcinosis | 1.26617091 |
| 55 | MP0003633_abnormal_nervous_system | 1.26049313 |
| 56 | * MP0000955_abnormal_spinal_cord | 1.23533773 |
| 57 | MP0005058_abnormal_lysosome_morphology | 1.21998027 |
| 58 | MP0001970_abnormal_pain_threshold | 1.21492408 |
| 59 | MP0001440_abnormal_grooming_behavior | 1.21104802 |
| 60 | MP0001963_abnormal_hearing_physiology | 1.20656097 |
| 61 | MP0000747_muscle_weakness | 1.19813686 |
| 62 | MP0002572_abnormal_emotion/affect_behav | 1.19775947 |
| 63 | * MP0002066_abnormal_motor_capabilities/c | 1.18486450 |
| 64 | MP0006276_abnormal_autonomic_nervous | 1.17427437 |
| 65 | MP0001661_extended_life_span | 1.15736475 |
| 66 | MP0008569_lethality_at_weaning | 1.12699874 |
| 67 | MP0005623_abnormal_meninges_morphology | 1.12111075 |
| 68 | MP0001346_abnormal_lacrimal_gland | 1.10901611 |
| 69 | MP0003075_altered_response_to | 1.10752827 |
| 70 | MP0003122_maternal_imprinting | 1.10495504 |
| 71 | MP0002295_abnormal_pulmonary_circulatio | 1.08981760 |
| 72 | MP0005386_behavior/neurological_phenoty | 1.08966202 |
| 73 | MP0004924_abnormal_behavior | 1.08966202 |
| 74 | MP0002822_catalepsy | 1.08468457 |
| 75 | MP0003123_paternal_imprinting | 1.08028985 |
| 76 | * MP0002752_abnormal_somatic_nervous | 1.07047521 |
| 77 | MP0001986_abnormal_taste_sensitivity | 1.06962830 |
| 78 | MP0002063_abnormal_learning/memory/cond | 1.05767777 |
| 79 | MP0001299_abnormal_eye_distance/ | 1.05676346 |
| 80 | MP0001851_eye_inflammation | 1.04064758 |
| 81 | MP0008438_abnormal_cutaneous_collagen | 1.03280130 |
| 82 | MP0002067_abnormal_sensory_capabilities | 1.02722625 |
| 83 | MP0000647_abnormal_sebaceous_gland | 1.01710988 |
| 84 | MP0005408_hypopigmentation | 0.98957182 |
| 85 | * MP0005195_abnormal_posterior_eye | 0.96108846 |
| 86 | MP0000566_synostosis | 0.94714209 |
| 87 | MP0003938_abnormal_ear_development | 0.94297587 |
| 88 | MP0000762_abnormal_tongue_morphology | 0.93778021 |
| 89 | MP0002733_abnormal_thermal_nociception | 0.92742358 |
| 90 | MP0004185_abnormal_adipocyte_glucose | 0.90688922 |
| 91 | MP0001348_abnormal_lacrimal_gland | 0.88167805 |
| 92 | MP0008874_decreased_physiological_sensi | 0.86697047 |
| 93 | MP0002638_abnormal_pupillary_reflex | 0.84828550 |
| 94 | MP0008877_abnormal_DNA_methylation | 0.84740406 |
| 95 | MP0000579_abnormal_nail_morphology | 0.83550375 |
| 96 | MP0003937_abnormal_limbs/digits/tail_de | 0.81701945 |
| 97 | MP0003656_abnormal_erythrocyte_physiolo | 0.80296973 |
| 98 | MP0000026_abnormal_inner_ear | 0.76631182 |
| 99 | MP0006072_abnormal_retinal_apoptosis | 0.75947453 |
| 100 | MP0002152_abnormal_brain_morphology | 0.75861565 |
| 101 | MP0001177_atelectasis | 0.74860879 |
| 102 | MP0008872_abnormal_physiological_respon | 0.72746944 |
| 103 | MP0004145_abnormal_muscle_electrophysio | 0.72353732 |
| 104 | MP0002735_abnormal_chemical_nociception | 0.72242019 |
| 105 | MP0005253_abnormal_eye_physiology | 0.71821155 |
| 106 | MP0005535_abnormal_body_temperature | 0.70882521 |
| 107 | MP0009840_abnormal_foam_cell | 0.70730653 |
| 108 | MP0004036_abnormal_muscle_relaxation | 0.70091722 |
| 109 | MP0002069_abnormal_eating/drinking_beha | 0.68103904 |
| 110 | MP0002909_abnormal_adrenal_gland | 0.66467933 |
| 111 | MP0010386_abnormal_urinary_bladder | 0.64384267 |
| 112 | MP0000467_abnormal_esophagus_morphology | 0.64078967 |
| 113 | MP0003172_abnormal_lysosome_physiology | 0.62778241 |
| 114 | MP0001968_abnormal_touch/_nociception | 0.62632673 |
| 115 | MP0001727_abnormal_embryo_implantation | 0.60203291 |
| 116 | MP0001340_abnormal_eyelid_morphology | 0.60097819 |
| 117 | MP0003137_abnormal_impulse_conducting | 0.60074210 |
| 118 | MP0000372_irregular_coat_pigmentation | 0.59782560 |
| 119 | MP0000749_muscle_degeneration | 0.59610823 |
| 120 | MP0002090_abnormal_vision | 0.59455427 |
| 121 | MP0005645_abnormal_hypothalamus_physiol | 0.58248341 |
| 122 | MP0005388_respiratory_system_phenotype | 0.58007923 |
| 123 | MP0002133_abnormal_respiratory_system | 0.58007923 |
| 124 | MP0002184_abnormal_innervation | 0.57495576 |
| 125 | MP0002736_abnormal_nociception_after | 0.57081161 |
| 126 | MP0000569_abnormal_digit_pigmentation | 0.56307023 |
| 127 | MP0004215_abnormal_myocardial_fiber | 0.55896764 |
| 128 | MP0002938_white_spotting | 0.55144910 |
| 129 | MP0010769_abnormal_survival | 0.53249453 |
| 130 | MP0004130_abnormal_muscle_cell | 0.51599399 |
| 131 | MP0010768_mortality/aging | 0.50097735 |
| 132 | MP0002082_postnatal_lethality | 0.49510996 |
| 133 | MP0010770_preweaning_lethality | 0.49510996 |
| 134 | MP0003283_abnormal_digestive_organ | 0.49205846 |
| 135 | MP0002653_abnormal_ependyma_morphology | 0.48830609 |
| 136 | MP0000639_abnormal_adrenal_gland | 0.47720176 |
| 137 | MP0001943_abnormal_respiration | 0.45750449 |
| 138 | MP0003956_abnormal_body_size | 0.45517800 |
| 139 | MP0003121_genomic_imprinting | 0.45425850 |
| 140 | MP0000631_abnormal_neuroendocrine_gland | 0.42743041 |
| 141 | MP0005166_decreased_susceptibility_to | 0.42392091 |
| 142 | MP0002873_normal_phenotype | 0.41629354 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 7.04371132 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 7.04371132 |
| 3 | Focal motor seizures (HP:0011153) | 6.41033675 |
| 4 | Neurofibrillary tangles (HP:0002185) | 6.39698380 |
| 5 | Parakeratosis (HP:0001036) | 5.40516264 |
| 6 | Focal seizures (HP:0007359) | 5.38903667 |
| 7 | Action tremor (HP:0002345) | 5.27800015 |
| 8 | Abnormality of the corticospinal tract (HP:0002492) | 5.23951999 |
| 9 | Febrile seizures (HP:0002373) | 4.95885945 |
| 10 | Abnormality of binocular vision (HP:0011514) | 4.85069959 |
| 11 | Diplopia (HP:0000651) | 4.85069959 |
| 12 | Epileptic encephalopathy (HP:0200134) | 4.76699733 |
| 13 | Sensory axonal neuropathy (HP:0003390) | 4.67439014 |
| 14 | Cerebral inclusion bodies (HP:0100314) | 4.60183906 |
| 15 | Atonic seizures (HP:0010819) | 4.55642357 |
| 16 | Peripheral hypomyelination (HP:0007182) | 4.40570354 |
| 17 | Abnormality of glycolysis (HP:0004366) | 4.20290656 |
| 18 | Increased serum pyruvate (HP:0003542) | 4.20290656 |
| 19 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.14131171 |
| 20 | Cerebral hypomyelination (HP:0006808) | 3.92042802 |
| 21 | Onion bulb formation (HP:0003383) | 3.74637114 |
| 22 | Supranuclear gaze palsy (HP:0000605) | 3.73206982 |
| 23 | Abnormal eating behavior (HP:0100738) | 3.70210864 |
| 24 | Generalized tonic-clonic seizures (HP:0002069) | 3.66592250 |
| 25 | Spastic gait (HP:0002064) | 3.61723931 |
| 26 | Insidious onset (HP:0003587) | 3.59680228 |
| 27 | Termporal pattern (HP:0011008) | 3.59680228 |
| 28 | Progressive cerebellar ataxia (HP:0002073) | 3.44035661 |
| 29 | Limb dystonia (HP:0002451) | 3.41377041 |
| 30 | Urinary urgency (HP:0000012) | 3.36177791 |
| 31 | Postural instability (HP:0002172) | 3.29246919 |
| 32 | Visual hallucinations (HP:0002367) | 3.28354123 |
| 33 | Leukodystrophy (HP:0002415) | 3.28245221 |
| 34 | Abnormal auditory evoked potentials (HP:0006958) | 3.23057631 |
| 35 | Absence seizures (HP:0002121) | 3.19120732 |
| 36 | Dialeptic seizures (HP:0011146) | 3.16216061 |
| 37 | Mutism (HP:0002300) | 3.07735276 |
| 38 | Alacrima (HP:0000522) | 3.07042257 |
| 39 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.04475690 |
| 40 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.04243627 |
| 41 | Papilledema (HP:0001085) | 3.03424650 |
| 42 | Hemiplegia (HP:0002301) | 3.01303294 |
| 43 | Intention tremor (HP:0002080) | 3.00320387 |
| 44 | Dysmetria (HP:0001310) | 3.00258124 |
| 45 | Retinal dysplasia (HP:0007973) | 2.92777599 |
| 46 | Torticollis (HP:0000473) | 2.92429659 |
| 47 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.91450009 |
| 48 | Slow saccadic eye movements (HP:0000514) | 2.83356534 |
| 49 | Delusions (HP:0000746) | 2.79944716 |
| 50 | Hemiparesis (HP:0001269) | 2.78798184 |
| 51 | Obstructive sleep apnea (HP:0002870) | 2.78426567 |
| 52 | Dysdiadochokinesis (HP:0002075) | 2.75265287 |
| 53 | Scanning speech (HP:0002168) | 2.75159171 |
| 54 | Truncal ataxia (HP:0002078) | 2.70896667 |
| 55 | Tetraplegia (HP:0002445) | 2.69762931 |
| 56 | Status epilepticus (HP:0002133) | 2.66017501 |
| 57 | Stridor (HP:0010307) | 2.65974375 |
| 58 | Absent septum pellucidum (HP:0001331) | 2.63428041 |
| 59 | Abnormality of the periventricular white matter (HP:0002518) | 2.63186042 |
| 60 | Myokymia (HP:0002411) | 2.62044433 |
| 61 | Cerebral hemorrhage (HP:0001342) | 2.61400701 |
| 62 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.61241458 |
| 63 | Ankle clonus (HP:0011448) | 2.61232884 |
| 64 | Hypoplastic pelvis (HP:0008839) | 2.61044848 |
| 65 | Spastic paraparesis (HP:0002313) | 2.60384140 |
| 66 | Anteriorly placed anus (HP:0001545) | 2.59372075 |
| 67 | Annular pancreas (HP:0001734) | 2.55759619 |
| 68 | Anxiety (HP:0000739) | 2.55576608 |
| 69 | Neuronal loss in central nervous system (HP:0002529) | 2.53951574 |
| 70 | Sleep apnea (HP:0010535) | 2.52999407 |
| 71 | Autoamputation (HP:0001218) | 2.52499901 |
| 72 | Renal Fanconi syndrome (HP:0001994) | 2.52480745 |
| 73 | Rigidity (HP:0002063) | 2.52312773 |
| 74 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.52017864 |
| 75 | Thickened helices (HP:0000391) | 2.50367594 |
| 76 | CNS hypomyelination (HP:0003429) | 2.49705084 |
| 77 | Bradykinesia (HP:0002067) | 2.46488837 |
| 78 | Clumsiness (HP:0002312) | 2.44417736 |
| 79 | Focal dystonia (HP:0004373) | 2.43355077 |
| 80 | Premature skin wrinkling (HP:0100678) | 2.42137519 |
| 81 | Epileptiform EEG discharges (HP:0011182) | 2.41184859 |
| 82 | Depression (HP:0000716) | 2.40529509 |
| 83 | Akinesia (HP:0002304) | 2.39291460 |
| 84 | Decreased lacrimation (HP:0000633) | 2.33809296 |
| 85 | Insomnia (HP:0100785) | 2.31839348 |
| 86 | Poor eye contact (HP:0000817) | 2.31030234 |
| 87 | Hepatosplenomegaly (HP:0001433) | 2.29847142 |
| 88 | Increased circulating renin level (HP:0000848) | 2.28071311 |
| 89 | Morphological abnormality of the inner ear (HP:0011390) | 2.27681477 |
| 90 | Craniofacial dystonia (HP:0012179) | 2.26238845 |
| 91 | Rapidly progressive (HP:0003678) | 2.22048627 |
| 92 | Muscle fiber splitting (HP:0003555) | 2.21810927 |
| 93 | Abnormality of the septum pellucidum (HP:0007375) | 2.21751723 |
| 94 | Acute necrotizing encephalopathy (HP:0006965) | 2.21094612 |
| 95 | Split foot (HP:0001839) | 2.19014368 |
| 96 | Apathy (HP:0000741) | 2.18554786 |
| 97 | Methylmalonic acidemia (HP:0002912) | 2.18018060 |
| 98 | Infantile muscular hypotonia (HP:0008947) | 2.17915403 |
| 99 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.15461220 |
| 100 | Pheochromocytoma (HP:0002666) | 2.13784052 |
| 101 | EEG with generalized epileptiform discharges (HP:0011198) | 2.12569609 |
| 102 | Spastic tetraparesis (HP:0001285) | 2.11868173 |
| 103 | Metabolic alkalosis (HP:0200114) | 2.11138128 |
| 104 | Partial agenesis of the corpus callosum (HP:0001338) | 2.10787238 |
| 105 | Foot dorsiflexor weakness (HP:0009027) | 2.10152747 |
| 106 | Coronal craniosynostosis (HP:0004440) | 2.09725024 |
| 107 | Patchy hypopigmentation of hair (HP:0011365) | 2.07889753 |
| 108 | Lower limb muscle weakness (HP:0007340) | 2.07495770 |
| 109 | Polyphagia (HP:0002591) | 2.06973056 |
| 110 | White forelock (HP:0002211) | 2.03559508 |
| 111 | Impaired smooth pursuit (HP:0007772) | 2.01939957 |
| 112 | Axonal loss (HP:0003447) | 2.01462822 |
| 113 | Megalencephaly (HP:0001355) | 2.01020348 |
| 114 | Hypsarrhythmia (HP:0002521) | 2.00026699 |
| 115 | 3-Methylglutaconic aciduria (HP:0003535) | 1.99567822 |
| 116 | Cupped ear (HP:0000378) | 1.98319207 |
| 117 | Aplasia of the phalanges of the hand (HP:0009802) | 1.97977955 |
| 118 | Aplasia involving bones of the extremities (HP:0009825) | 1.97977955 |
| 119 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.97977955 |
| 120 | Erythroderma (HP:0001019) | 1.97924075 |
| 121 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.97626919 |
| 122 | Partial duplication of thumb phalanx (HP:0009944) | 1.97502110 |
| 123 | Hypophosphatemic rickets (HP:0004912) | 1.97317727 |
| 124 | Gaze-evoked nystagmus (HP:0000640) | 1.96625717 |
| 125 | Hypoplasia of the iris (HP:0007676) | 1.96244913 |
| 126 | Diminished motivation (HP:0000745) | 1.96115446 |
| 127 | Hypomagnesemia (HP:0002917) | 1.95836005 |
| 128 | Bundle branch block (HP:0011710) | 1.93476458 |
| 129 | Abnormal social behavior (HP:0012433) | 1.92840595 |
| 130 | Impaired social interactions (HP:0000735) | 1.92840595 |
| 131 | Decreased motor nerve conduction velocity (HP:0003431) | 1.92020803 |
| 132 | Amblyopia (HP:0000646) | 1.91350940 |
| 133 | Hypokalemic alkalosis (HP:0001949) | 1.90714137 |
| 134 | Acute encephalopathy (HP:0006846) | 1.90086272 |
| 135 | Broad-based gait (HP:0002136) | 1.89654132 |
| 136 | Abnormality of the foot musculature (HP:0001436) | 1.89439197 |
| 137 | Hyporeflexia of lower limbs (HP:0002600) | 1.88940422 |
| 138 | Duplicated collecting system (HP:0000081) | 1.88562632 |
| 139 | Neuroendocrine neoplasm (HP:0100634) | 1.88523980 |
| 140 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.88219951 |
| 141 | Spastic paraplegia (HP:0001258) | 1.88007630 |
| 142 | Esophageal atresia (HP:0002032) | 1.87382447 |
| 143 | Abnormality of saccadic eye movements (HP:0000570) | 1.86380081 |
| 144 | Paraplegia (HP:0010550) | 1.85614162 |
| 145 | Bowel incontinence (HP:0002607) | 1.84958944 |
| 146 | Poor speech (HP:0002465) | 1.84536862 |
| 147 | Impaired vibratory sensation (HP:0002495) | 1.83655441 |
| 148 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.83285229 |
| 149 | Paraparesis (HP:0002385) | 1.82324368 |
| 150 | Abnormality of cochlea (HP:0000375) | 1.81598039 |
| 151 | Incomplete penetrance (HP:0003829) | 1.79878237 |
| 152 | Urinary incontinence (HP:0000020) | 1.79141020 |
| 153 | Stereotypic behavior (HP:0000733) | 1.77396118 |
| 154 | Humeroradial synostosis (HP:0003041) | 1.76350073 |
| 155 | Synostosis involving the elbow (HP:0003938) | 1.76350073 |
| 156 | Clonus (HP:0002169) | 1.76219110 |
| 157 | Mitochondrial inheritance (HP:0001427) | 1.75200254 |
| 158 | Progressive macrocephaly (HP:0004481) | 1.75104115 |
| 159 | Prolonged neonatal jaundice (HP:0006579) | 1.75052325 |
| 160 | Choreoathetosis (HP:0001266) | 1.74856487 |
| 161 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.74010802 |
| 162 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.73879450 |
| 163 | Hammertoe (HP:0001765) | 1.72398792 |
| 164 | Postnatal microcephaly (HP:0005484) | 1.71647675 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 6.42218860 |
| 2 | OXSR1 | 4.56588923 |
| 3 | NTRK3 | 4.13972613 |
| 4 | EPHB1 | 3.84107536 |
| 5 | DAPK2 | 3.34133166 |
| 6 | PBK | 2.86995392 |
| 7 | WNK4 | 2.84940246 |
| 8 | BCR | 2.80826351 |
| 9 | CDK19 | 2.70502701 |
| 10 | PKN1 | 2.69204696 |
| 11 | PRKD3 | 2.42533884 |
| 12 | MAPKAPK5 | 2.39521503 |
| 13 | MET | 2.36485554 |
| 14 | TESK2 | 2.32675985 |
| 15 | CAMKK1 | 2.14271734 |
| 16 | MINK1 | 2.11866493 |
| 17 | MAP3K9 | 2.06674537 |
| 18 | FGFR2 | 2.06535093 |
| 19 | LIMK1 | 2.06262409 |
| 20 | WNK1 | 2.06190753 |
| 21 | CSNK1G3 | 1.94521157 |
| 22 | CSNK1A1L | 1.88674851 |
| 23 | PNCK | 1.83577014 |
| 24 | MST4 | 1.82650634 |
| 25 | UHMK1 | 1.79438138 |
| 26 | PLK2 | 1.65827106 |
| 27 | CAMK2B | 1.61552126 |
| 28 | PINK1 | 1.57938835 |
| 29 | CSNK1G1 | 1.54157866 |
| 30 | NEK6 | 1.50458868 |
| 31 | CSNK1G2 | 1.44958578 |
| 32 | TNIK | 1.43400300 |
| 33 | ROCK2 | 1.42077314 |
| 34 | GRK5 | 1.42019021 |
| 35 | NTRK1 | 1.41871386 |
| 36 | FGR | 1.39515781 |
| 37 | ICK | 1.36523036 |
| 38 | CAMK2D | 1.34600968 |
| 39 | CLK1 | 1.33363566 |
| 40 | CAMK1 | 1.33319479 |
| 41 | PRKCG | 1.25152268 |
| 42 | RIPK4 | 1.20842862 |
| 43 | PRPF4B | 1.15706892 |
| 44 | ALK | 1.15299576 |
| 45 | RIPK1 | 1.14133791 |
| 46 | PAK6 | 1.13473215 |
| 47 | SGK494 | 1.11553115 |
| 48 | SGK223 | 1.11553115 |
| 49 | DYRK2 | 1.06446642 |
| 50 | DAPK1 | 1.05690574 |
| 51 | CAMK2G | 1.03595103 |
| 52 | SGK2 | 1.00055153 |
| 53 | SIK2 | 0.99920846 |
| 54 | CASK | 0.97987805 |
| 55 | CAMKK2 | 0.97597302 |
| 56 | EPHA4 | 0.96391653 |
| 57 | MAPK12 | 0.89715811 |
| 58 | ARAF | 0.89192641 |
| 59 | TYRO3 | 0.88784558 |
| 60 | MARK1 | 0.87932839 |
| 61 | MARK2 | 0.86978099 |
| 62 | LATS2 | 0.86453520 |
| 63 | CDK14 | 0.85578764 |
| 64 | PRKCQ | 0.85350757 |
| 65 | SGK1 | 0.83497853 |
| 66 | TNK2 | 0.83332372 |
| 67 | CAMK2A | 0.83124516 |
| 68 | MAPK10 | 0.81085947 |
| 69 | BMPR1B | 0.79058705 |
| 70 | SGK3 | 0.78701670 |
| 71 | MUSK | 0.77668871 |
| 72 | PRKD1 | 0.77476919 |
| 73 | CDK5 | 0.76809119 |
| 74 | CDK15 | 0.76372955 |
| 75 | MAPK15 | 0.74114859 |
| 76 | PAK3 | 0.72611561 |
| 77 | STK38 | 0.71560938 |
| 78 | CDK18 | 0.70587660 |
| 79 | CDK11A | 0.69118540 |
| 80 | PRKCZ | 0.66829868 |
| 81 | PDPK1 | 0.65620049 |
| 82 | ERBB4 | 0.64607798 |
| 83 | MAP3K13 | 0.63873398 |
| 84 | PRKCE | 0.63205737 |
| 85 | TRPM7 | 0.62068691 |
| 86 | RPS6KA3 | 0.61614925 |
| 87 | PHKG2 | 0.60570288 |
| 88 | PHKG1 | 0.60570288 |
| 89 | RPS6KA5 | 0.60569818 |
| 90 | BRSK1 | 0.60422180 |
| 91 | MAP3K4 | 0.58616454 |
| 92 | MAP3K11 | 0.56569079 |
| 93 | FES | 0.54750798 |
| 94 | FYN | 0.53792352 |
| 95 | LMTK2 | 0.53410059 |
| 96 | CAMK4 | 0.53337983 |
| 97 | CSNK1D | 0.51903312 |
| 98 | ILK | 0.49684551 |
| 99 | PRKG1 | 0.49372212 |
| 100 | CAMK1G | 0.47425299 |
| 101 | CSNK1A1 | 0.44802080 |
| 102 | PAK1 | 0.44122246 |
| 103 | GRK7 | 0.43650022 |
| 104 | IRAK2 | 0.43306713 |
| 105 | PRKCA | 0.43225567 |
| 106 | PRKACB | 0.42948624 |
| 107 | ROCK1 | 0.42295687 |
| 108 | GSK3A | 0.41482738 |
| 109 | PIK3CA | 0.38540480 |
| 110 | MAP2K2 | 0.37165041 |
| 111 | ADRBK2 | 0.36987682 |
| 112 | KSR2 | 0.36567720 |
| 113 | MAP2K4 | 0.36475476 |
| 114 | MAP2K7 | 0.35741471 |
| 115 | PRKCH | 0.34732303 |
| 116 | NTRK2 | 0.34716561 |
| 117 | MKNK1 | 0.34547023 |
| 118 | OBSCN | 0.34520927 |
| 119 | STK11 | 0.34430830 |
| 120 | ERBB2 | 0.34322976 |
| 121 | PRKG2 | 0.32992241 |
| 122 | DDR2 | 0.32226949 |
| 123 | BRAF | 0.30854821 |
| 124 | BLK | 0.30612899 |
| 125 | PRKCB | 0.30386766 |
| 126 | KSR1 | 0.30276547 |
| 127 | PTK2B | 0.29085334 |
| 128 | PDK1 | 0.28903919 |
| 129 | RAF1 | 0.28775436 |
| 130 | SRC | 0.28369746 |
| 131 | DAPK3 | 0.27974736 |
| 132 | PRKACA | 0.27485430 |
| 133 | MOS | 0.26941262 |
| 134 | MAP2K6 | 0.26019483 |
| 135 | ITK | 0.25906208 |
| 136 | INSR | 0.25234634 |
| 137 | MAPK7 | 0.24919228 |
| 138 | PDGFRB | 0.23872044 |
| 139 | BMX | 0.23347246 |
| 140 | CSNK1E | 0.23010483 |
| 141 | BMPR2 | 0.22556462 |
| 142 | DYRK1A | 0.22280621 |
| 143 | GRK1 | 0.21378414 |
| 144 | MAPK13 | 0.19400951 |
| 145 | LCK | 0.19300071 |
| 146 | ABL2 | 0.18608016 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 5.94934253 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.91022303 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.80762922 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.97547849 |
| 5 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.14004025 |
| 6 | Ether lipid metabolism_Homo sapiens_hsa00565 | 3.02531564 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.77910053 |
| 8 | Insulin secretion_Homo sapiens_hsa04911 | 2.64102775 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.62629999 |
| 10 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.60761052 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.55446407 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.30670331 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.23254800 |
| 14 | Protein export_Homo sapiens_hsa03060 | 2.22289463 |
| 15 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.06875465 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.99599718 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88381290 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.77474346 |
| 19 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.75384786 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.74857304 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.72871507 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.71699942 |
| 23 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.65966012 |
| 24 | Parkinsons disease_Homo sapiens_hsa05012 | 1.61366907 |
| 25 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.56135514 |
| 26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.55657911 |
| 27 | Axon guidance_Homo sapiens_hsa04360 | 1.51375154 |
| 28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.49725145 |
| 29 | Alzheimers disease_Homo sapiens_hsa05010 | 1.48184919 |
| 30 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.46560313 |
| 31 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.46494750 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.42886143 |
| 33 | Olfactory transduction_Homo sapiens_hsa04740 | 1.26353196 |
| 34 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.23713179 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.16930910 |
| 36 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.14774590 |
| 37 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.13570890 |
| 38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.11793777 |
| 39 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.10775411 |
| 40 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.09821277 |
| 41 | GABAergic synapse_Homo sapiens_hsa04727 | 1.09522814 |
| 42 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.09493505 |
| 43 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.06331246 |
| 44 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.05321616 |
| 45 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.02297277 |
| 46 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.02228967 |
| 47 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.01408820 |
| 48 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.98221700 |
| 49 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.98162049 |
| 50 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.93658919 |
| 51 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.93149223 |
| 52 | Gap junction_Homo sapiens_hsa04540 | 0.92893739 |
| 53 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.90223193 |
| 54 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.88280084 |
| 55 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.87803642 |
| 56 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.87380477 |
| 57 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.86702473 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.85689910 |
| 59 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.84972309 |
| 60 | Melanogenesis_Homo sapiens_hsa04916 | 0.83577850 |
| 61 | Huntingtons disease_Homo sapiens_hsa05016 | 0.81412633 |
| 62 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.81112375 |
| 63 | Morphine addiction_Homo sapiens_hsa05032 | 0.80635915 |
| 64 | Glioma_Homo sapiens_hsa05214 | 0.79896570 |
| 65 | Tight junction_Homo sapiens_hsa04530 | 0.78848565 |
| 66 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77860419 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77746305 |
| 68 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.76098301 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75398482 |
| 70 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.73460143 |
| 71 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.73332498 |
| 72 | Long-term depression_Homo sapiens_hsa04730 | 0.73232278 |
| 73 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.71584036 |
| 74 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.70397642 |
| 75 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69098285 |
| 76 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68848105 |
| 77 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67654630 |
| 78 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.66532771 |
| 79 | Peroxisome_Homo sapiens_hsa04146 | 0.62622190 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.62277466 |
| 81 | Lysosome_Homo sapiens_hsa04142 | 0.61654867 |
| 82 | Circadian rhythm_Homo sapiens_hsa04710 | 0.61232377 |
| 83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60823441 |
| 84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60618019 |
| 85 | Phototransduction_Homo sapiens_hsa04744 | 0.60072588 |
| 86 | Cocaine addiction_Homo sapiens_hsa05030 | 0.58437436 |
| 87 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.58255813 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.56251338 |
| 89 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.56119768 |
| 90 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56022626 |
| 91 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.54473326 |
| 92 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.53134307 |
| 93 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52826704 |
| 94 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.52583015 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52020396 |
| 96 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51934405 |
| 97 | ABC transporters_Homo sapiens_hsa02010 | 0.51016757 |
| 98 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50728817 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | 0.50232719 |
| 100 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.47874742 |
| 101 | Circadian entrainment_Homo sapiens_hsa04713 | 0.47389250 |
| 102 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45458586 |
| 103 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.45188201 |
| 104 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.43967843 |
| 105 | Phagosome_Homo sapiens_hsa04145 | 0.43697418 |
| 106 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.43376800 |
| 107 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42995322 |
| 108 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42556077 |
| 109 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.41309407 |
| 110 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40939359 |
| 111 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40698957 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40693883 |
| 113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.40317879 |
| 114 | Salivary secretion_Homo sapiens_hsa04970 | 0.40042082 |
| 115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.39673502 |
| 116 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.38431978 |
| 117 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.37991131 |
| 118 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.37314174 |
| 119 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.36456942 |
| 120 | Retinol metabolism_Homo sapiens_hsa00830 | 0.35381558 |
| 121 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.34846346 |
| 122 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.34500850 |
| 123 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.33993750 |
| 124 | Malaria_Homo sapiens_hsa05144 | 0.33785061 |
| 125 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.33175273 |
| 126 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.32095933 |
| 127 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.31533536 |
| 128 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.31068834 |
| 129 | Nicotine addiction_Homo sapiens_hsa05033 | 0.30142018 |
| 130 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.26781170 |
| 131 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.26517300 |
| 132 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.26460730 |
| 133 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.26247367 |
| 134 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.25238547 |
| 135 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.23964432 |
| 136 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.23629597 |
| 137 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.23041527 |
| 138 | Prion diseases_Homo sapiens_hsa05020 | 0.20517945 |
| 139 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.19342928 |
| 140 | Taste transduction_Homo sapiens_hsa04742 | 0.19141528 |
| 141 | Renin secretion_Homo sapiens_hsa04924 | 0.18957765 |
| 142 | Alcoholism_Homo sapiens_hsa05034 | 0.18288197 |
| 143 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.18182266 |
| 144 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.17060827 |

